Aurentz Vincent
SEC insider (Form 3/4/5 filer). CIK 0001657494. Director at Inhibikase Therapeutics, Inc. (IKT) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Feb 21, 2026. Located in WILMINGTON, DE.
Companies Aurentz Vincent has filed insider reports for
- Inhibikase Therapeutics, Inc. (IKT): Director
- Longboard Pharmaceuticals, Inc. (LBPH): Director
Aurentz Vincent
CIK: 0001657494
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Feb 21, 2026IKT
Inhibikase Therapeutics, Inc.
DispositionDirect255.3K shares- - Jun 30, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
108.2K shares- - Feb 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
134.4K shares- - Feb 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
134.4K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
12.4K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
12.4K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
22.5K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
12.5K shares- - Dec 2, 2024LBPH
Longboard Pharmaceuticals, Inc.
DispositionDirectEmployee Stock Option (right to buy)
7.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 21, 2026 |  IKT Inhibikase Therapeutics, Inc. | Disposition | 255,299 | - | $0 | Direct |
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 108,176 | - | - | Direct |
| Feb 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 134,427 | - | - | Direct |
| Feb 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 134,427 | - | - | Direct |
| Dec 2, 2024 |  LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 12,367 | - | - | Direct |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 12,367 | - | - | Direct |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 22,500 | - | - | Direct |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 12,500 | - | - | Direct |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | Disposition Employee Stock Option (right to buy) | 7,214 | - | - | Direct |
1-9 of 9 transactions